Stocksigma LogoStocksigma Logo

Rekvina Laboratories Schedules Board Meeting for 13th Nov'26 to Consider Q2 Results

Rekvina Laboratories Limited has scheduled a meeting of its Board of Directors on 13th Nov'26 to consider and approve the unaudited Ind AS financial

Rekvina Laboratories Schedules Board Meeting for 13th Nov'26 to Consider Q2 Results

Rekvina Laboratories Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Rekvina Laboratories Schedules Board Meeting for 13th Nov'26 to Consider Q2 Results Rekvina Laboratories Limited has scheduled a meeting of its Board of Directors on 13th Nov'26 to consider and approve the unaudited Ind AS financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for designated persons has been closed from 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Rekvina Laboratories Ltd

All Rekvina Laboratories Ltd announcements